Isolation of transformation-suppressor genes by using a cDNA-expression library having sense and anti-sense inserts.

使用具有正义和反义插入片段的 cDNA 表达文库分离转化抑制基因。

基本信息

  • 批准号:
    02454145
  • 负责人:
  • 金额:
    $ 4.42万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

1. We used artificial overexpression of cDNAs synthesized from NIH3T3 cell mRNA to induce reversion of NIH3T3 cells transformed by the activated Harvey-ras oncogene. The revertants were screened by observation under microscope for "flat" appearance. Among about 100 revertant cell lines obtained, we have chosen one revertant, Rev6-4, which showed marked decrease in its ability to form colonies in soft agar and to form tumors in nude mice, and isolated an incorporatcd cDNA from its genomic DNA by molecular cloning after PCR (polymerase chain reaction) amplification.2. Analysis of the CDNA isolated from Rev6-4 showed that the CDNA encoded P68, which had been shown to have ATP-dependent RNA helicase activity, and that the cDNA appeared to be over-expressed in an anti-sense manner in Rev6-4 cells. Concominantly, a decrease in the amount of endogenous P68 mRNA was observed. We have confirmed that the cloned Rev6-4 CDNA could induce decrease in colony formation in soft agar, in tumor formation in nude mice and in saturation density when overexpressed in the ras-transformed NIH3T3 cells in the anti-sense manner.3. We have isolated a full-length cDNA encoding P68. When the cDNA was over-expressed in NIH3T3 cells in a sense direction, formation of foci which appeared morphologically-transformed was observed.However, cells in the foci could not form tumors when injected into nude mice. Presently, we do not know if the P68 gene is an oncogene whose product is acting in downstream of ras. We are currently analysing a physiological function of P68 by using antibodies against it.4. We have isolated cDNAs from two other revertants and are currently analysing their structure and examining for their ability to induce reversion.
1.我们利用人工过表达由NIH 3 T3细胞mRNA合成的cDNA来诱导由活化的Harvey-ras癌基因转化的NIH 3 T3细胞的逆转。通过在显微镜下观察“扁平”外观筛选回复突变体。从获得的100株回复突变株中,筛选出软琼脂集落形成能力和裸鼠成瘤能力明显下降的回复突变株Rev 6 -4,并通过PCR扩增后的分子克隆,从其基因组DNA中分离得到了一个特异性的cDNA.从Rev 6 -4分离的cDNA的分析表明,该cDNA编码P68,其已被证明具有ATP依赖性RNA解旋酶活性,并且该cDNA似乎在Rev 6 -4细胞中以反义方式过表达。与此同时,内源性P68 mRNA的量减少。我们已经证实,克隆的Rev 6 -4 cDNA以反义方式在ras转化的NIH 3 T3细胞中过表达时,可以诱导软琼脂集落形成、裸鼠成瘤以及饱和密度的降低.我们已经分离出了编码P68的全长cDNA。当该cDNA在NIH 3 T3细胞中以正义方向过表达时,观察到形成了形态学转化的病灶,但病灶中的细胞注射到裸鼠体内时不能形成肿瘤。目前尚不清楚P68基因是否是一种癌基因,其产物是否作用于ras下游。我们目前正在分析P68的生理功能,通过使用抗体。我们已经从另外两个回复突变体中分离出cDNA,目前正在分析它们的结构,并研究它们诱导回复突变的能力。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
片岡 徹: "がん遺伝子と抑制遺伝子(第3章分担執筆)" 東京大学出版会, 143 (1991)
片冈彻:《癌基因和抑制基因(第3章合著者)》东京大学出版社,143(1991)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. KATAOKA: Tokyo Univ. Press. Oncogenes and anti-oncogenes (third chapter only), 143 (1991)
T.片冈:东京大学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Noboru Suzuki 5: "Leucine-rich repeats and caarboxyl terminus are required for interaction of yeast adenylate cyclase with RAS proteins" Proceedings of the National Academy of Sciences,USA. 87. 8711-8715 (1990)
Noboru Suzuki 5:“酵母腺苷酸环化酶与 RAS 蛋白相互作用需要富含亮氨酸的重复序列和羧基末端”美国国家科学院院刊。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
J.Field 5: "Cloning and Characterization of CAP,the S.cerevisiae Gene Encoding the 70kd Adenylyl Cyclase-Associated Protein" Cell. 61. 319-327 (1990)
J.Field 5:“CAP(编码 70kd 腺苷酸环化酶相关蛋白的酿酒酵母基因)细胞的克隆和表征”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATAOKA Tohru其他文献

KATAOKA Tohru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATAOKA Tohru', 18)}}的其他基金

Analysis of the function of Rap1-activating factors which mediate the cross-talks between different species of small G proteins
Rap1激活因子介导不同物种小G蛋白间串扰的功能分析
  • 批准号:
    20390080
  • 财政年份:
    2008
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism of cell growth regulation by small G proteins
小G蛋白调节细胞生长的机制
  • 批准号:
    17014061
  • 财政年份:
    2005
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Elucidation of the in vivo function of the Ras/Rap effector phospholipase Cε
阐明 Ras/Rap 效应磷脂酶 Cε 的体内功能
  • 批准号:
    17390078
  • 财政年份:
    2005
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the Regulatory Mechanism and Function of a Novel Class of Phospholipase C, PLCε
一类新型磷脂酶 C PLCε 的调控机制和功能分析
  • 批准号:
    15390093
  • 财政年份:
    2003
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the Function of a Novel Class of Mammalian Phospholipase C, PLCε
一类新型哺乳动物磷脂酶 C (PLCε) 的功能分析
  • 批准号:
    13470022
  • 财政年份:
    2001
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Mechanism of Regulation of Effector Activities by Small GTP-binding Proteins
小 GTP 结合蛋白调节效应子活性的分子机制
  • 批准号:
    11470034
  • 财政年份:
    1999
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Elucidation of the Molecular Mechanism Underlying the Stimulatory Effect of Posttranslational Lipid Modification of Ras Protein on Activation of Its Effectors
阐明 Ras 蛋白翻译后脂质修饰对其效应子激活的刺激作用的分子机制
  • 批准号:
    09470031
  • 财政年份:
    1997
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Significance of Posttranslational Modification (Farnesylation) of Ras Protein in Activation of Its Effectors
Ras 蛋白翻译后修饰(法呢基化)对其效应子激活的意义
  • 批准号:
    08457038
  • 财政年份:
    1996
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a Strategy for Selective Inhibition of a Particular Ras Function by Interfering Ras-Effector Interaction
通过干扰 Ras-效应器相互作用来选择性抑制特定 Ras 功能的策略的开发
  • 批准号:
    07557333
  • 财政年份:
    1995
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Mechanism of Intracellular Signaling via Ras Protein
Ras 蛋白的细胞内信号传导机制
  • 批准号:
    06280218
  • 财政年份:
    1994
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas

相似国自然基金

RNA helicase DHX33 调节肝脏发育的机制研究
  • 批准号:
    31771603
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of RNA helicase Ddx5 in pathological cardiac remodeling
RNA解旋酶Ddx5在病理性心脏重塑中的作用
  • 批准号:
    10718560
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
Arginine methylation of the RNA helicase DDX5 in the regulation of RNA/DNA hybrids during the DNA damage response.
RNA 解旋酶 DDX5 的精氨酸甲基化在 DNA 损伤反应期间调节 RNA/DNA 杂交体中的作用。
  • 批准号:
    487619
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Operating Grants
THE RNA HELICASE EIF4A IS A THERAPEUTIC VULNERABILITY IN TRIPLE-NEGATIVE BREAST CANCER
RNA解旋酶EIF4A是三阴性乳腺癌的治疗漏洞
  • 批准号:
    10582328
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
Regulatory roles of the RNA helicase DDX5 in male germline stem cells
RNA解旋酶DDX5在雄性生殖干细胞中的调节作用
  • 批准号:
    DP220103555
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Discovery Projects
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
  • 批准号:
    BB/X511560/1
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Training Grant
The role of the RNA helicase DDX3X in Burkitt Lymphoma and its potential as a new therapeutic target
RNA解旋酶DDX3X在伯基特淋巴瘤中的作用及其作为新治疗靶点的潜力
  • 批准号:
    461753
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Operating Grants
Role of RNA helicase DDX1 in influenza A virus replication
RNA解旋酶DDX1在甲型流感病毒复制中的作用
  • 批准号:
    10439323
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
Exploring the role of the RNA helicase DDX1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX1 在 B 淋巴细胞 DNA 修复过程十字路口的作用
  • 批准号:
    2757627
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Studentship
RNP remodeling by RNA helicase UAP56
RNA解旋酶UAP56对RNP进行重构
  • 批准号:
    21K06016
  • 财政年份:
    2021
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the function of arginine methylation of the RNA helicase Vasa in germ granule formation and localization
RNA解旋酶Vasa精氨酸甲基化在胚芽颗粒形成和定位中的功能分析
  • 批准号:
    21K15039
  • 财政年份:
    2021
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了